← Back to Company DatabaseVisit Website
Color Health
Population-scale health programs for hereditary cancer risk screening.
Series C+Burlingame, CAFounded 2013
About
Color Health provides technology infrastructure for large-scale health programs including hereditary cancer genetic testing. The company offers cancer genetic risk assessment panels and works with employers, health systems, and government programs to make cancer screening more accessible. Color has also expanded into broader population health initiatives.
Total Funding
$278MKey Product
Color hereditary cancer genetic testGeography
North AmericaKey Investors
General CatalystViking Global InvestorsT. Rowe Price
Focus Areas
Early Detection / ScreeningDiagnostics
Technology
Genomics / SequencingDigital Health / Software
Cancer Types
BreastColorectalPan-cancer
Last updated: Feb 4, 2026